Genesco (GCO) EBITDA (2010 - 2026)

Genesco's EBITDA history runs 17 years deep, the most recent figure standing at -$15.4 million for Q2 2026.

• On a quarterly basis, EBITDA rose 45.37% year-over-year to -$15.4 million in Q2 2026; TTM through May 2026 was $30.1 million, a 67.98% increase from a year earlier, with the FY2026 full-year figure at $17.3 million, up 24.34% from the prior year.
• EBITDA declined to -$15.4 million in Q2 2026 per GCO's latest filing, from $51.3 million in the prior quarter.
• Across five years, EBITDA topped out at $83.4 million in Q1 2022 and bottomed at -$38.6 million in Q3 2023.
• The 5-year median for EBITDA is $8.8 million (2022), against an average of $9.9 million.
• Across the five-year window, EBITDA sank 525.31% in 2023 and soared 73.4% in 2024, its largest moves.
• Year by year, EBITDA stood at $26.1 million in 2022, then slumped by 58.38% to $10.9 million in 2023, then fell by 5.92% to $10.2 million in 2024, then dropped by 16.0% to $8.6 million in 2025, then slumped by 279.3% to -$15.4 million in 2026.
• Per Business Quant, the three latest GCO EBITDA figures stand at -$15.4 million (Q2 2026), $51.3 million (Q1 2026), and $8.6 million (Q4 2025).